Table 3.
Spearman correlation coefficient ρ (Control n=6, Patient n= 55) | |||||||||
---|---|---|---|---|---|---|---|---|---|
ANRIL | H19 | HOTAIR | HULC | MALAT1 | MEG3 | MIAT | WISPER | ZFAS1 | |
Control n = 6 | |||||||||
ρ | -0.45 | 0.23 | -0.42 | -0.18 | -0.58 | 0.57 | -0.17 | -0.40 | -0.33 |
P-value | 0.224 | 0.546 | 0.265 | 0.637 | 0.099 | 0.112 | 0.668 | 0.286 | 0.381 |
Patient n = 55 | |||||||||
ρ | 0.029 | -0.080 | 0.057 | 0.001 | -0.070 | -0.112 | -0.077 | 0.040 | -0.008 |
P-value | 0.836 | 0.574 | 0.681 | 0.996 | 0.611 | 0.415 | 0.576 | 0.774 | 0.956 |
Combined P and C, n=61 | |||||||||
ρ | 0.001 | 0.023 | 0.000 | 0.060 | -0.135 | -0.022 | 0.005 | 0.076 | -0.024 |
P-value | 0.993 | 0.860 | 0.998 | 0.645 | 0.299 | 0.864 | 0.967 | 0.562 | 0.851 |
Spearman's rank correlation coefficients of lncRNAs and Creatinine expression. To obtain p-values, t-statistic was used.
Method:
1. Similar to HbA1c.